Literature DB >> 31125530

Salvinorin A attenuates early brain injury through PI3K/Akt pathway after subarachnoid hemorrhage in rat.

Juan Sun1, Xiaomei Yang2, Yan Zhang2, Weiguang Zhang2, Jianfei Lu3, Qin Hu3, Renyu Liu4, Changman Zhou2, Chunhua Chen5.   

Abstract

Early brain injury (EBI) refers to the direct injury to the brain during the first 72 h after subarachnoid hemorrhage (SAH), which is one of the major causes for the poor clinical outcome after SAH. In this study, we investigated the effect and the related mechanism of Salvinorin A (SA), a selective kappa opioid receptor agonist, on EBI after SAH. SA was administered by intraperitoneal injection at 24 h, 48 h and 72 h after SAH. The volume of lateral ventricle was measured by magnetic resonance imaging (MRI). The neuronal morphological changes and the apoptotic level in CA1 area of hippocampus were observed by Nissl and TUNEL staining respectively. Protein expression of p-PI3K, p-Akt, p-IKKα/β, p-NF-κB, FoxO1, Bim, Bax and Cleaved-caspase-3 was measured to explore the potential mechanism. We found that SA alleviated the neuronal morphological changes and apoptosis in CA1 area of hippocampus. The mechanism might be related to the increased protein expression of p-PI3K/p-Akt, which accompanied by decreased expression of p-IKKα/β, p-NF-κB, FoxO1, Bim, Bax and Cleaved-caspase-3 in the hippocampus. Thus, therapeutic interventions of SA targeting the PI3K/Akt pathway might be a novel approach to ameliorate EBI via reducing the apoptosis and inflammation after SAH.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Early brain injury; PI3K/Akt; Salvinorin A; Subarachnoid hemorrhage

Year:  2019        PMID: 31125530     DOI: 10.1016/j.brainres.2019.05.026

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

Review 2.  Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects.

Authors:  Andreia Machado Brito-da-Costa; Diana Dias-da-Silva; Nelson G M Gomes; Ricardo Jorge Dinis-Oliveira; Áurea Madureira-Carvalho
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-03

3.  Neurons derived from human-induced pluripotent stem cells express mu and kappa opioid receptors.

Authors:  Zhi-Hai Ju; Xuan Liang; Yao-Yao Ren; Luo-Wa Shu; Yan-Hong Yan; Xu Cui
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

4.  ACE2 Rescues Impaired Autophagic Flux Through the PI3K/AKT Pathway After Subarachnoid Hemorrhage.

Authors:  Lujun Pang; Zhao Liu; Ke Zhou; Peng Chen; Enyu Pan; Yanjun Che; Xin Qi
Journal:  Neurochem Res       Date:  2021-10-27       Impact factor: 4.414

5.  Action mechanism of early cerebral injuries after spontaneous subarachnoid hemorrhage by silence Ghrelin and angiogenic factor with G-patch and FHA domain 1.

Authors:  Jianxun Tang; Ligang Hu; Feng Long; Jie Zhang; Jingfeng Tang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 6.  Biological Effects and Mechanisms of Caspases in Early Brain Injury after Subarachnoid Hemorrhage.

Authors:  Yiwen Wu; Yuchun Liu; Chenhui Zhou; Yuefei Wu; Jie Sun; Xiang Gao; Yi Huang
Journal:  Oxid Med Cell Longev       Date:  2022-07-05       Impact factor: 7.310

Review 7.  Role of Anesthetics and Their Adjuvants in Neurovascular Protection in Secondary Brain Injury after Aneurysmal Subarachnoid Hemorrhage.

Authors:  Umeshkumar Athiraman; Gregory J Zipfel
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.